Claritas announces launch of Mitochondrial DNA Analysis

Orderable as a component of the Claritas Clinical Exome

January 30, 2017

Claritas is pleased to announce the addition of the mitochondrial DNA analysis to their Flagship Claritas Clinical Exome. When ordered, the mitochondrial genome and exome are sequenced simultaneously by deep NGS sequencing. More information is available here.

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.